|
|
|
Insider
Information: |
Silvernail Lauren P |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
207,068 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,121,751 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
207,068 |
|
|
Total
Value |
$2,121,751 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-60.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ISTA Pharmaceuticals Inc |
ISTA |
CFO & VP Corporate Dev... |
2012-06-06 |
0 |
2005-05-12 |
0 |
Premium* |
|
Revance Therapeutics, Inc. |
RVNC |
CFO & CBO |
2018-05-22 |
65,497 |
2014-05-19 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
See Remarks |
2022-05-18 |
141,571 |
2018-05-29 |
0 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2006-02-16 |
4 |
A |
$0.00 |
$6 |
D/D |
5,600 |
12,721 |
|
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2006-02-16 |
4 |
A |
$0.00 |
$6 |
D/D |
5,600 |
10,600 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2007-02-02 |
4 |
A |
$0.00 |
$7 |
D/D |
7,000 |
17,600 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-08 |
4 |
A |
$0.00 |
$11 |
D/D |
10,500 |
26,769 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2009-02-03 |
4 |
A |
$0.00 |
$9 |
D/D |
9,000 |
52,353 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2010-02-02 |
4 |
A |
$0.00 |
$9 |
D/D |
9,000 |
60,584 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-02-07 |
4 |
A |
$0.00 |
$11 |
D/D |
10,950 |
66,442 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-11-30 |
4 |
A |
$0.00 |
$27 |
D/D |
27,375 |
123,880 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Seretary & EVP Corp Dev. |
|
2014-05-19 |
4 |
A |
$32.22 |
$451,080 |
D/D |
14,000 |
14,000 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,290 |
23,270 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2015-06-30 |
4 |
A |
$14.16 |
$8,963 |
D/D |
633 |
633 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2015-12-31 |
4 |
A |
$27.00 |
$9,153 |
D/D |
339 |
22,758 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2016-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,695 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2016-06-30 |
4 |
A |
$11.56 |
$8,658 |
D/D |
749 |
30,691 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
40,691 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2017-06-30 |
4 |
A |
$18.32 |
$11,064 |
D/D |
604 |
60,170 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2017-12-29 |
4 |
A |
$22.99 |
$10,186 |
D/D |
443 |
66,955 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,125 |
74,090 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
53,388 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2020-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
93,388 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
180,689 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
53,571 |
219,967 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2017-10-12 |
4 |
AS |
$26.67 |
$297,760 |
D/D |
(11,164) |
49,006 |
0 |
- |
|
78 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|